1
Return

Platelet membrane-fusing MSC-derived apoptotic extracellular vesicles enhanced cardiac repair after ischemia/reperfusion injury

delete2026-07-21
delete0
PRE
AI
Z
Zhifeng Song
F
Fangshun Tan
Y
Yu Jiang
S
Shuo Wang
Z
ZhiYao Wei
M
Miao Yu
H
Hongrui Yu
Y
Yanxia Tu
L
Liaoming He
W
Weixian Yang *
H
Hai‐Yan Qian *
DOI:10.1007/s13346-026-02178-7delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Myocardial ischemia/reperfusion injury (I/RI) is a common complication following percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Mesenchymal stem cell-derived apoptotic vesicles (MSC-apoVs) seem to be a promising cell-free therapy for alleviating cardiac I/RI, but their therapeutic efficiency is hindered by insufficient targeting capability in vivo. The present study aims to explore the platelet membrane-modified apoVs (P-apoVs), utilizing the nature affinity of platelets for apoV delivery to the injured vascular and myocardial sites. P-apoVs exhibited excellent physicochemical properties, and microRNA (miRNA)-sequencing showed that the extrusion process had no detrimental effects on the content and distribution of miRNAs. Compared to non-modified apoVs, the cellular uptake of P-apoVs was greatly enhanced in bone marrow-derived macrophages (BMDMs), human umbilical vein endothelial cells (HUVECs) stressed by oxygen glucose deprivation/reperfusion (OGD/R) and neonatal rat cardiomyocytes (NRCMs) stressed by OGD/R. Functionally, P-apoVs inhibited the apoptosis of OGD/R NRCMs, promoted BMDM polarization toward M2 phenotype, as well as enhanced HUVEC migration and tube formation in vitro. In the myocardial I/RI model, P-apoVs preferentially accumulated in the injured myocardial sites and attenuate cardiac modeling after I/RI without systemic toxicity. In conclusion, this engineering platelet-modified apoVs shows potential as a therapeutic strategy for myocardial I/RI.
Keywords:
Myocardial ischemia/reperfusion injury
Apoptotic vesicles
Platelet-mimetic
Targeted delivery

Journal

Drug Delivery and Translational Research cover
Drug Delivery and Translational Research
IF:
5.5
Papers:
2.2K
Citations:
7.4K

Organization

N
National Center for Cardiovascular Diseases
Scholars:
264
Papers: 65
Citations: 0
F
fuwai hospital
Scholars:
216
Papers: 63
Citations: 0
C
capital medical university
Scholars:
1.2W
Papers: 3.2K
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers